| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/30/2009 | WO2006138606A3 Cell signaling genes and related methods |
| 04/30/2009 | WO2006083964A3 Modified fusion molecules for treatment of allergic disease |
| 04/30/2009 | WO2006009890A3 Methods and compositions for producing insulin sensitization |
| 04/30/2009 | WO2005098016A3 Methods for producing hyaluronic acid |
| 04/30/2009 | WO2005059101A3 Novel sodium channel |
| 04/30/2009 | US20090111973 Monolconal antibody specific to single immunoglobulin and toll-interleukin-1 receptor domain (SIGIRR) for treatment of rheumatoid arthritis, osteoporosis and inflammatory bowel diseases |
| 04/30/2009 | US20090111765 Compositions and methods for immunostimulatory rna oligonucleotides |
| 04/30/2009 | US20090111747 Anti-Diabetic or Anti-Hypertensive Dietary Supplement |
| 04/30/2009 | US20090111745 Plad Domain Peptides With Increased Serum Half Life Due To Conjugation To Domain Antibodies |
| 04/30/2009 | US20090111195 Chemical reagents and methods for detection and quantification of proteins in complex mixtures |
| 04/30/2009 | US20090111183 Ketone Ligands for Modulating the Expression of Exogenous Genes Via An Ecdysone Receptor Complex |
| 04/30/2009 | US20090111160 fusion protein has trypsin and/or chymotrypsin loop being replaced with a vascular endothelial growth factor binding peptide; a culture product; anticarcinogenic agents, antitumor agents; antiinflammatory agent for treating cartilage and bone disorder; treating dermatitis |
| 04/30/2009 | US20090111148 producing a dehydrated immobilized enzyme catalyst having improved specific activity upon rehydration and use of the enzyme catalyst for the conversion of glycolonitrile to glycolic acid |
| 04/30/2009 | US20090111147 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides |
| 04/30/2009 | US20090111146 Antibody Drug |
| 04/30/2009 | US20090111145 Production of hetero-oligomeric proteins in plants |
| 04/30/2009 | US20090111144 Transactivation system for mammalian cells |
| 04/30/2009 | US20090111143 Methods and Compositions for Mammalian Cell Lines for Transfection and Protein Expression in Serum-Free Medium |
| 04/30/2009 | US20090111142 Method for manufacturing a recombinant polyclonal protein |
| 04/30/2009 | US20090111129 Methods and Kits for Detecting Fungal Infection |
| 04/30/2009 | US20090110770 Galactosidase With Alpha-Galactosyltransferase Activity |
| 04/30/2009 | US20090110686 Antibodies against CCR5 and uses thereof |
| 04/30/2009 | US20090110682 Antibody Having Inhibitory Effect on Amyloid Fibril Formation |
| 04/30/2009 | US20090110677 Polypeptide regulating phosphate metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same |
| 04/30/2009 | US20090110670 Drug screening; selecting a lactic acid bacterial strain for administration to a mammal for reducing gastrointestinal inflammation; culturing a Lactobacillus strain, obtaining a cell-free culture supernatant from the strain and evaluating the level of TNF alpha in the supernatant using a model system |
| 04/30/2009 | US20090110659 Immunoglobulin specific to eotaxin for use in diagnosis, prevention and treatment of infections, autoimmune, inflammatory and allergic disorders; chemotactic cytokines designated human eotaxins; selectively modulate leukocyte function |
| 04/30/2009 | CA2703787A1 Antibody directed against pro-gastrin releasing peptide, and use thereof |
| 04/30/2009 | CA2703493A1 A cell for use in production of heteroproteins and production method using the same |
| 04/30/2009 | CA2703483A1 Protein based foaming agents and methods of making thereof |
| 04/30/2009 | CA2703086A1 Method for purifying protein |
| 04/30/2009 | CA2695237A1 Anti-rantes antibodies and methods of use thereof |
| 04/29/2009 | EP2053126A1 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 04/29/2009 | EP2052713A2 Soluble FcgammaR fusion proteins and methods of use thereof |
| 04/29/2009 | EP2052083A2 Genetically programmed expression of selectively sulfated proteins in eubacteria |
| 04/29/2009 | EP1976985A4 Methods and compositions related to mutant kunitz domain i of tfpi-2 |
| 04/29/2009 | EP1541686B1 CONSTRUCTION OF ANTIBODY USING MRL/lPR MOUSE |
| 04/29/2009 | EP1461357B1 Novel hev antigenic peptide and methods |
| 04/29/2009 | EP1423137B1 Lipopeptide stereoisomers, methods for preparing same, and useful intermediates |
| 04/29/2009 | EP1373488B1 Heat stable mutants of starch biosynthesis enzymes |
| 04/29/2009 | EP1218509B1 Fibroblast growth factor-like polypeptides |
| 04/29/2009 | EP1105413B1 Hepatitis c inhibitor tri-peptides |
| 04/29/2009 | EP0835315B1 Vaccine for porcine reproductive and respiratory syndrome virus |
| 04/29/2009 | CN101421411A Taurine transporter gene |
| 04/29/2009 | CN101421403A Compositions and methods for humanization and optimization of n-glycans in plants |
| 04/29/2009 | CN101421301A Transducible delivery of sirna by dsrna binding domain fusions to ptd/cpps |
| 04/29/2009 | CN101420969A Agent for preventing arteriosclerosis, agent for suppressing vascular intimal thickening and agent for improving vascular endothelial function |
| 04/29/2009 | CN101418330A Non protein culture medium adapted to large-scale culture of NSO cell and production of antibody |
| 04/29/2009 | CN101418329A Preparation method of rapeseed proteolysis peptides based on pulse ultrasonic technology and use thereof |
| 04/29/2009 | CN101418328A Method for producing fish scale collagen protein |
| 04/29/2009 | CN101418290A High efficiency ELP fusion protease as well as preparation and application thereof |
| 04/29/2009 | CN101418271A Bacillus amyloliquefaciens producing lipopeptide to promote fungi apoptosis and lipopeptide prepared by the same and use |
| 04/29/2009 | CN101418045A Immunoglobulin variants and uses thereof |
| 04/29/2009 | CN101418044A Immunoglobulin variants and uses thereof |
| 04/29/2009 | CN101418043A Immunoglobulin variants and uses thereof |
| 04/29/2009 | CN101418038A Highland barley peptide and preparation method thereof |
| 04/29/2009 | CN101418037A Yak bone peptide and preparation method thereof |
| 04/29/2009 | CN100482801C Promoters for expressing genes in fungal cell |
| 04/29/2009 | CN100482797C Plant fatty acid epoxygenase genes and uses therefor |
| 04/29/2009 | CN100482796C Expression of recombinant ox growth hormone in pichia pastoris |
| 04/29/2009 | CN100482795C IREN protein, its preparation and use |
| 04/29/2009 | CN100482688C Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof |
| 04/29/2009 | CN100482684C Cytokine protein family |
| 04/29/2009 | CN100482283C Novel chimeric CD154 |
| 04/29/2009 | CN100482276C Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 04/28/2009 | US7524938 using a hapten comprising tetracarboxy phenyl porphyrin zinc or cobalt complexes, to generate monoclonal or polyclonal antibodies and testing for inhibitory effects of the antibodies on the gelatinase B; metalloenzyme inhibitors |
| 04/28/2009 | US7524931 Full-length interferon gamma polypeptide variants |
| 04/28/2009 | US7524930 polypeptides consisting of amino acid sequences or peptide fragments and drug carriers, used for inducing and/or activating human leukocyte antigens (HLA-A2)-restricted tumor-specific cytotoxic T lymphocytes; anticancer vaccines |
| 04/28/2009 | US7524816 Peptides and supported peptides for treating skin diseases |
| 04/28/2009 | US7524813 Selectively conjugated peptides and methods of making the same |
| 04/28/2009 | US7524676 Large scale productions of virus antigen |
| 04/28/2009 | US7524667 Mutated 6-phosphogluconate dehydrogenase |
| 04/28/2009 | US7524666 Reductase gene and use thereof |
| 04/28/2009 | US7524664 Regio- and enantioselective alkane hydroxylation with modified cytochrome P450 |
| 04/28/2009 | US7524660 Utilization of fructose in microbial production strains |
| 04/28/2009 | US7524657 Alleles of the sigA gene from coryneform bacteria |
| 04/28/2009 | US7524656 Ability to produce L-glutamic acid, arginine or lysine is incrreased by increasing expression of a specific protein, e.g., by increasing the copy number of the DNA coding for the protein |
| 04/28/2009 | US7524655 Recombinantly and transgenically produced glycoproteins; efficient method for enzymatically synthesizing glycoconjugates having the desired fucoylated oligosaccharide moieties |
| 04/28/2009 | US7524649 Chimeric polypeptide having a modified binding domain of growth hormone linked to a receptor binding domain of growth hormone receptor; treating giantism; acromegaly; cancer diabetic retinopathy; diabetic nephropathy, diabetic complications and any disease of growth hormone excess |
| 04/28/2009 | US7524648 Expression system for enhancing solubility and immunogeneicity of recombinant proteins |
| 04/28/2009 | US7524647 Biosynthesis; orthogonal tRNAs, orthogonal aminoacyl-tRNA synthetases |
| 04/28/2009 | US7524646 Using mutant amino acid adaptor/carrier proteins to alter amino acid content of polypetides; directed protein evolution |
| 04/28/2009 | US7524645 Nucleic acid sequences of truncated or mutated alternansucrases, vectors containing these nucleic acids sequences, host cells transformed with the nucleic acid sequences; high level of expression while retaining enzymatic activity |
| 04/28/2009 | US7524644 Expression vector comprising enzymatic polypeptide for use in prevention and treatment of blood clots; thrombolytic agents |
| 04/28/2009 | US7524643 Nucleotide sequences coding voltage gated calcium channels (VGCC) for treating neurological and cardiovascular disorders; anticonvulsant |
| 04/28/2009 | US7524627 Contains connecting disulfide bridge; humanized monoclonal and polyclonal antibodies; generating and/or increasing an immunogenic response directed against Respiratory Syncytial Virus |
| 04/28/2009 | US7524507 Enhancing expression of protein in gsstrointestinal mucosal cells of mammal by placing in recombinant gut-colonizing bacterium (Salmonella), attenuated so mammal does not experience significant harmful infectious effects; vaccines |
| 04/28/2009 | US7524502 Modified anti-TNF alpha antibody |
| 04/28/2009 | US7524498 Human immunomodulatory monoclonal antibodies for the treatment of cancer |
| 04/28/2009 | US7524497 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide |
| 04/28/2009 | US7524492 Insulin related transcription factor and uses thereof |
| 04/28/2009 | CA2191978C Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests |
| 04/28/2009 | CA2133017C Process for producing desired substance using acetic acid-resistant recombinant escherichia microorganism |
| 04/28/2009 | CA1341595C Procedure for obtaining dna, rna, peptides, polypeptides, or proteins byrecombinant dna techniques |
| 04/23/2009 | WO2009051769A1 Method and composition for crystallizing g protein-coupled receptors |
| 04/23/2009 | WO2009051226A1 Method for production of stable mutant protein |
| 04/23/2009 | WO2009051201A1 Anti-bst2 antibody |
| 04/23/2009 | WO2009051109A1 Method of constructing cells with high productivity of foreign protein |
| 04/23/2009 | WO2009051108A1 Method for production of antibody |
| 04/23/2009 | WO2008140477A8 Hybrid immunoglobulins with moving parts |
| 04/23/2009 | WO2008078180A3 Materials and methods for the generation of transcripts comprising modified nucleotides |